On Point: Paracrine's Cell Therapy Uses Adipose-Derived Rege

GEN Edge meets with Paracrine chairman and CEO Christopher J. Calhoun to discuss how the company's namesake treatment will reduce the need for lifelong therapies by repairing the underlying structural condition of damaged cells.

Related Keywords

, Celution System ,